VERTEX PHARMACEUTICALS INC
VRTX·92532F100·US·Common Stock·Healthcare - Biotechnology-13D/G
VRTX (VERTEX PHARMACEUTICALS INC) is held by 345 institutional investors as of Q2 2026. Largest holders: Capital World Investors ($13B), BlackRock, Inc. ($12B), Capital Research Global Investors ($9.7B). Net institutional sentiment: Mixed. In Q2 2026, 5 members of Congress and 183 funds bought VRTX.
Who's Trading
Source dates: Price Oct 14, 2026 · Insiders Sep 10, 2026 · Activists May 14, 2026 · Congress Aug 5, 2026
Top Holders
Showing 1-20 of 358
Continue exploring
Other Healthcare stocks held by institutions
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer